|
DNAJA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.658500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.123600E-01 |
| Normal-vs-Stage2 |
2.936800E-01 |
| Normal-vs-Stage3 |
1.517900E-02 |
| Normal-vs-Stage4 |
3.727700E-02 |
| Stage1-vs-Stage2 |
4.165800E-01 |
| Stage1-vs-Stage3 |
4.681700E-02 |
| Stage1-vs-Stage4 |
2.409500E-02 |
| Stage2-vs-Stage3 |
5.113800E-01 |
| Stage2-vs-Stage4 |
2.536200E-01 |
| Stage3-vs-Stage4 |
4.157400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.019300E-03 |
| Normal-vs-AfricanAmerican |
9.863600E-01 |
| Normal-vs-Asian |
6.797800E-01 |
| Caucasian-vs-AfricanAmerican |
6.174400E-02 |
| Caucasian-vs-Asian |
9.697800E-01 |
| AfricanAmerican-vs-Asian |
6.808400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.100260E-02 |
| Normal-vs-Female |
1.638400E-01 |
| Male-vs-Female |
8.721200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.658600E-01 |
| Normal-vs-Extreme_Weight |
1.789040E-01 |
| Normal-vs-Obese |
7.320000E-02 |
| Normal-vs-Extreme_Obese |
4.462800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.769000E-01 |
| Normal_Weight-vs-Obese |
3.398600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.030000E-01 |
| Extreme_Weight-vs-Obese |
5.543000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.041000E-01 |
| Obese-vs-Extreme_Obese |
8.423600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.833800E-02 |
| Normal-vs-Age(41-60Yrs) |
9.862100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.757900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.488800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.603790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.685400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.042200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.867800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.358800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.533600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.154400E-02 |
| Normal-VS-Type2 PRCC |
1.411990E-02 |
| Normal-VS-KIRP CIMP |
7.750400E-02 |
| Normal-VS-Unclassified PRCC |
1.055770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.659360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.359750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.259400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.958220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.687600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.982640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.585400E-01 |
| Normal-vs-N1 |
4.948000E-02 |
| Normal-vs-N2 |
8.332200E-01 |
| N0-vs-N1 |
2.437400E-01 |
| N0-vs-N2 |
9.363200E-01 |
| N1-vs-N2 |
5.675800E-01 |
|
|
